| Subject: | FDA Warns of Possible Risks from Infant Heel Warmers |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Thu, 9 Jul 2009 - 12:00 pm |
| The Food and Drug Administration (FDA) is advising healthcare professionals about possible risks from the use of infant heel warmers. These devices are disposable heat packs used during neonatal care to increase circulation in the infant's heel. Activating the pack produces a chemical reaction that produces heat to approximately 104 degrees F. When the pack is applied to the heel, the heat increases capillary circulation, and this helps to draw blood during a heel stick. Although... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
Related MCN Products:
|
|
With over 20 years experience in regulatory compliance, MCN Healthcare brings you the most comprehensive regulatory compliance tool available. StayAlert! is the only comprehensive e-mail notification service available that not only notifies you of the changes in major federal regulations, but also provides the policies, procedures, tools and best practices to help you meet the changing regulation. StayAlert! actively monitors TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others so you don't have to. The StayAlert! system was designed by healthcare professionals actively working in the healthcare environment, who were faced with attempting to competently provide quality care and services while "doing more with less". StayAlert! provides the answer to efficiently performing a variety of required job components from one centralized virtual location. StayAlert! improves data sharing and communications, thus reducing cost, broadening access and providing a system of documentation and follow-up. |
|
